Home / Diseases Index / Pemphigus Vulgaris
🩺 Clinical Pathology & Repertory Reference

Pemphigus Vulgaris

Comprehensive Diagnostic & Therapeutic Reference Profile

Also known as: PV, Acantholytic Pemphigus, Pemphigus Vegetans (variant)

📖
Section 1

Disease Overview

Pemphigus Vulgaris (PV) is a rare, severe autoimmune blistering disease characterized by the loss of intercellular connections between keratinocytes (acantholysis). It primarily affects the skin and mucous membranes, resulting in fragile, painful bullae that rupture easily, leaving raw, denuded areas. If untreated, the condition is potentially fatal due to fluid loss, electrolyte imbalance, and secondary infections.

🏥
Section 2

Medical Classification

Disease Category
Dermatological Diseases
ICD Classification
ICD-10: L10.0
🧬
Section 3

Etiology & Causes

PV is an autoimmune disorder triggered by the production of autoantibodies against desmoglein 1 and 3 (desmosomal proteins). Genetic predisposition (specifically HLA-DRB10402 and HLA-DQB10503 alleles) plays a significant role. Environmental triggers may include certain medications (e.g., penicillamine, captopril) and physical stressors like UV radiation or thermal burns.

⚙️
Section 4

Pathophysiology

The primary mechanism involves IgG autoantibodies binding to desmoglein (Dsg) proteins within desmosomes. This binding triggers intracellular signaling and enzyme activation (plasminogen activators), causing the breakdown of cellular adhesion (acantholysis). This loss of cohesion leads to intraepidermal blistering, occurring just above the basal layer (suprabasal clefting).

📊
Section 5

Epidemiology

PV typically manifests in adults between the ages of 40 and


  1. There is no significant gender predilection. Prevalence varies globally, often higher in populations of Ashkenazi Jewish, Mediterranean, and Middle Eastern descent.

⚠️
Section 6

Risk Factors

  • Genetic predisposition (HLA alleles)
  • Drug exposure (thiol-containing drugs)
  • Age (40–60 years)
  • History of autoimmune disease
  • Environmental triggers (e.g., UV exposure)
🤒
Section 8

Symptoms

A. Early Symptoms


  • Oral mucosal erosions

  • Persistent painful mouth ulcers

  • Gingival inflammation B. Common Symptoms

  • Fragile, flaccid bullae

  • Positive Nikolsky sign (skin shears with light pressure)

  • Erosions on the scalp or trunk C. Advanced Symptoms

  • Extensive body denudation

  • Profound pain

  • Secondary bacterial skin infections D. Emergency Symptoms

  • High fever

  • Sepsis

  • Severe dehydration

  • Difficulty swallowing or breathing due to airway involvement

🩺
Section 9

Physical Examination

Inspection reveals flaccid bullae that rupture, leaving painful erosions. Palpation demonstrates a positive Nikolsky sign and an Asboe-Hansen sign (blister extension on pressure). Oral cavity assessment usually shows ulcerative stomatitis.

🔍
Section 10

Diagnostic Evaluation

A. Clinical Assessment: History of mucosal involvement and physical sign testing.
B. Laboratory Testing: ELISA for anti-Dsg1 and anti-Dsg3 antibodies.
C. Imaging Studies: Generally not required unless assessing for underlying malignancy (paraneoplastic).
D. Functional Tests: Not applicable.
E. Biopsy Findings: Direct Immunofluorescence (DIF) showing intercellular IgG/C3 deposits; histology showing suprabasal acantholysis.
F. Genetic Testing: Not routinely performed.
G. Differential Diagnosis: Bullous pemphigoid, Cicatricial pemphigoid, Stevens-Johnson Syndrome.

🧪
Section 11

Laboratory Tests

Test Name: Anti-Desmoglein 1 & 3 ELISA
Type: Blood Test
Purpose: Identify autoimmune antibodies
Expected Findings: Elevated IgG
Interpretation: Diagnostic confirmation

📷
Section 12

Imaging Studies

Typically not indicated for routine PV. Chest X-rays may be ordered if paraneoplastic pemphigus is suspected, to check for underlying thymoma or lymphoma.

🔀
Section 13

Differential Diagnosis

  • Bullous Pemphigoid (deeper subepidermal, less mucosal involvement)
  • Erythema Multiforme (target lesions)
  • Lichen Planus (erosive form)
💢
Section 14

Complications

  • Secondary sepsis
  • Electrolyte imbalance
  • Chronic steroid side effects (osteoporosis, hyperglycemia)
  • Malnutrition due to oral pain
💊
Section 15

Treatment Options

A. Lifestyle Modifications: Soft diet, oral hygiene.
B. Preventive Measures: UV protection, avoidance of culprit medications.
C. Medical Treatment: Corticosteroids (Prednisone), Immunosuppressants (Azathioprine, Mycophenolate Mofetil), and Biologics (Rituximab).
D. Surgical Treatment: Wound debridement.
E. Interventional Procedures: Plasmapheresis.
F. Rehabilitation: Physical therapy for chronic cases.
G. Emergency Management: IV fluids, electrolyte correction, ICU admission for sepsis.

📉
Section 16

Prognosis

Historically fatal, but the prognosis has improved significantly with modern immunosuppressive therapy. Most patients achieve disease remission, though long-term maintenance therapy is often required.

🛡️
Section 17

Prevention

No primary prevention exists. Secondary prevention involves regular monitoring for signs of relapse and medication side effects.

🌿
Section 19

Homeopathic Perspective

The following homeopathic remedies have been historically indicated for symptoms associated with Pemphigus Vulgaris. Selection should be based on individualized symptom totality and constitutional assessment.

📝 Clinical Notes:
Learn about Pemphigus Vulgaris, a rare autoimmune blistering disease. Explore symptoms, diagnosis, and evidence-based treatments.
Section 20

FAQs

Q: What is Pemphigus Vulgaris?
Pemphigus Vulgaris (PV) is a rare, severe autoimmune blistering disease characterized by the loss of intercellular connections between keratinocytes (acantholysis). It primarily affects the skin and mucous membranes, resulting in fragile, painful bullae that rupture easily, leaving raw, denuded area...
Q: What are the main symptoms of Pemphigus Vulgaris?
A. Early Symptoms - Oral mucosal erosions - Persistent painful mouth ulcers - Gingival inflammation B. Common Symptoms - Fragile, flaccid bullae - Positive Nikolsky sign (skin shears with light pressure) - Erosions on the scalp or trunk C. Advanced Symptoms - Extensive body denudation - Profound pai...
Q: What causes Pemphigus Vulgaris?
PV is an autoimmune disorder triggered by the production of autoantibodies against desmoglein 1 and 3 (desmosomal proteins). Genetic predisposition (specifically HLA-DRB1*0402 and HLA-DQB1*0503 alleles) plays a significant role. Environmental triggers may include certain medications (e.g., penicilla...
Q: Which homeopathic remedies are recommended for Pemphigus Vulgaris?
Based on clinical repertory references, recommended remedies include: Hydrocotyle Asiatica, Caltha Palustris. Selection should be individualized based on the patient's complete symptom picture.
Q: When should I see a doctor for Pemphigus Vulgaris?
Consult a healthcare professional if you experience persistent or worsening symptoms, or if the condition significantly impacts your daily activities.
📚
Section 21

References

  • Homeopathy by Hadhrat Mirza Tahir Ahmad (r.a.) — Primary clinical reference
  • Robin Murphy — Lotus Materia Medica (3rd Edition)
  • William Boericke — Pocket Manual of Homœopathic Materia Medica & Repertory
  • ICD-10/ICD-11 Classification — World Health Organization
  • Harrison's Principles of Internal Medicine (Reference Standard)

This clinical reference profile is compiled from authoritative medical sources for educational purposes. Always verify clinical data with current medical guidelines.

📊
Section 22

Clinical Calculator

📊 Chronic Fatigue Syndrome (CFS) Severity Index

Evaluates Chronic Fatigue Syndrome (CFS/ME) severity by assessing post-exertional malaise (PEM), unrefreshing sleep patterns, cognitive fog, and orthostatic symptoms.

🧪 Chronic Fatigue Syndrome (CFS) Severity Index

Evaluates Chronic Fatigue Syndrome (CFS/ME) severity by assessing post-exertional malaise (PEM), unrefreshing sleep patterns, cognitive fog, and orthostatic symptoms.

Enter your clinical parameters to see dynamic diagnostic readings.

📊 Chronic Fatigue Syndrome (CFS) Severity Index

Evaluates Chronic Fatigue Syndrome (CFS/ME) severity by assessing post-exertional malaise (PEM), unrefreshing sleep patterns, cognitive fog, and orthostatic symptoms.

🚀 Open Calculator Page

Clinical Specifications

Reference ID CPD-90284
Disease Group Dermatological Diseases
Content Sections 20 Active Sections

Clinical Consultation

Speak with our specialists for a customized treatment protocol for this condition.

📅 Request Consultation

Medical Disclaimer

This clinical reference is for educational purposes only. It is not a substitute for professional medical diagnosis or treatment. Always consult a licensed healthcare practitioner.

Advertisement
📖 Click any word to see its definition instantly! ×